Skip to content

Effect of Titrated Administration of Ciprofol Combined with Remifentanil on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial

Effect of Titrated Administration of Ciprofol Combined with Remifentanil on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115824
Enrollment
Unknown
Registered
2025-12-31
Start date
2026-01-07
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative hypotension in elderly patients undergoing laparoscopic abdominal surgery

Interventions

Titrated group:Anesthesia induction was performed by continuous infusion of propofol at a rate of 3 mg/kg/h, combined with remifentanil at 1.2 µg/kg, until the patient lost consciousness, as indicated
Controled group:Routine induction and maintenance were performed using remimazolam and remifentanil. Remimazolam was administered at an initial dose of 0.2 mg/kg for induction. Following endotracheal
however, the monitor screen was positioned facing away from the anesthesiologist.

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 65 years old, scheduled for elective laparoscopic abdominal surgery 2. ASA grade 1-3 3. Requiring invasive arterial blood pressure monitoring

Exclusion criteria

Exclusion criteria: 1. Patients currently participating in other clinical trials that may affect the interventions or observations of this study will be excluded. 2. Those with severe liver or kidney disease (GFR= 180 mmHg or DBP >= 110 mmHg); 4. Patients with severe mental disorders (such as schizophrenia), epilepsy, or Parkinson’s disease, severe cognitive or intellectual impairment, severe visual or hearing impairments affecting assessment, or long-term alcohol abuse or use of sedative/analgesic medications; 5. Patients with a history of allergy to the drugs used in this study; 6. Patients requiring continuous intravenous vasoconstrictors before the start of surgery, or those whose blood pressure needs prolonged regulation and intervention during surgery due to surgical reasons; 7. Expected blood loss > 15% of total blood volume; 8. Expected surgical duration 6 hours; 9. Expected postoperative hospital stay < 72 hours.

Design outcomes

Primary

MeasureTime frame
Rate of hypotension;

Secondary

MeasureTime frame
The time-weighted area under the curve (TWA) for MAP <65 mmHg during the anesthesia period;Cumulative dose of norepinephrine and the proportion of patients requiring vasoactive support;;The time-weighted area under the curve (TWA) for MAP <0.8 baseline during the anesthesia period;Time to first hypotensive episode;Cardiac index(CI) trend ;The time periods with a higher incidence of hypotension between the two groups;Intraoperative ciprofol and remifentanil dose per unit time;Whether blood pressure variability (CV) and the average rate of blood pressure variation (ARV) are different.;The incidence of severe intraoperative hypotension;The time from general anesthesia drug discontinuation to awakening.;The rate of postoperative delirium;Postoperative complications;The mortality rate and readmission rate within 30 days after the operation.;The lowest MAP during surgery ;

Countries

China

Contacts

Public ContactJin Sanqing

The Sixth Affiliated Hospital of Sun Yat-sen University

sanqingjin@hotmail.com+86 137 1936 6863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026